化学科学与工程前沿(英文版)(Frontiers of Chemical Science and Engineering)

化学科学与工程前沿(英文版)(Frontiers of Chemical Science and Engineering) 知网万方目次维普目次

  • CSCD
  • 科核
  • 高T2
  • EI(中国2024)
基本信息
  • 主管单位:

    教育部

  • 主办单位:

    高等教育出版社有限公司、中国工程院、天津大学

  • 国际刊号:

    2095-0179;EISSN2095-0187

  • 国内刊号:

    11-5981/TQ

  • 学科分类:

    化学

  • 字数:

    18000-54000

  • 有无基金:

    /有基金 100.0%

  • 周期:

    CN外文-月刊

  • 特殊属性:

    第一批认定学术期刊

联系信息
  • 电话:

    010-58556658;87402150

  • 邮箱:

    fcse@tju.edu.cn、chengll@hep.com.cn(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

    知网,万方目次,维普目次

  • 级别:

    CSCD,科核,高T2,EI(中国2024)

期刊简介

《化学科学与工程前沿(英文版)(Frontiers of Chemical Science and Engineering)》期刊已被查看:

更新频次

单位占比

一作占比

/有基金-100.0%

投稿指南

1、投稿方式:在线投稿。

2、刊内网址:(202306期)

http://journal.hep.com.cn

https://link.springer.com

3、官网网址:http://journal.hep.com.cn/fcse/

https://www.springer.com/journal/11705

https://link.springer.com/journal/11705/

4、、投稿系统:

http://mc.manuscriptcentral.com/fcse

5、出刊日期:月刊,每月出版1期。

2023年8月28星期一

《化学科学与工程前沿(英文版)》投稿指南

Guide for Authors (June, 2023)

【官网信息】

FRONTIERS OF CHEMICAL SCIENCE AND ENGINEERING

Guide for Authors (June, 2023)

1 General Information

Frontiers of Chemical Science and Engineering is an international peer-reviewed academic journal sponsored by the Ministry of Education of China. The journal is administered by Higher Education Press, Chinese Academy of Engineering and Tianjin University, jointly published by Higher Education Press and Springer-Verlag on a monthly basis in English. Online versions are available at https://link.springer.com/journal/11705/volumes-and-issues or http://journal.hep.com.cn/fcse.

1.1 General

All contributions should conform to the Aims and Scope shown at the front of the journal. The Editors welcome contributions to new topics that fall within the broad scope of Chemical Science and Engineering.

1.2 Ethical Responsibilities of Authors

This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines (http://publicationethics.org/resources/guidelines) on how to deal with potential acts of misconduct.

1.3 Disclosure of Potential Conflict of Interests

A conflict of interest may exist when an author or the author’s institution has a financial or other relationship with other people or organizations that may inappropriately influence the author’s work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.

1.4 Statement of Human and Animal Rights

When reporting studies that involve human participants, authors should include a statement that the studies have been approved by the appropriate institutional and/or national research ethics committee and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. If doubt exists whether the research was conducted in accordance with the 1964 Helsinki Declaration or comparable standards, the authors must explain the reasons for their approach, and demonstrate that the independent ethics committee or institutional review board explicitly approved the doubtful aspects of the study.

1.5 Articles Types

Research articles should be complete and authoritative accounts of work which have special significance, general interest and which are presented clearly and concisely. Research articles should be in the range of 8‒12 journal pages in length. In research articles, author’s self-citation rate should not exceed 20%.

Review articles In addition to undergoing the same rigorous level of technical peer-review as Research articles, Review articles will be critiqued based on the general impact of the field being reviewed, the relevance of the field to experimental mechanics, preexisting reviews of the field, and acknowledgement of the contributing author as a dominant figure in the field. Review articles typically occupy 10‒15 journal pages. In review articles, author’s self-citation rate should be lower than 25%.

Communications dealing with new ideas and specific points rather than developing a theme, and should not exceed 4 journal pages.

Views & Comments presenting important views and comments on keys issues, significant progress, or crucial problems that need to be solved, and may be submitted by invitation. For the length of Views & Comments, up to 4 pages can be accepted.

Note: in formatted papers, there are 600 words in each journal page on average (figures, tables, references and footnotes are included).

2 Submission of Manuscripts

Authors can submit their papers via the online submission system: http://mc.manuscriptcentral.com/fcse, the Chief Editor and one of the Associate Editors with whom the author can communicate efficiently or whose expertise covers the content of the paper. Submit your manuscript as a Word file. Other file types are not suitable for production. It is important that the file be saved in the native format of the wordprocessor used. All correspondence, including the editor’s decision and request for revisions, will be by e-mail. After reviewing process, the manuscript will be finally judged by one of the editors who have the right to accept or reject a paper.

……

更多详情:

https://journal.hep.com.cn/fcse/EN/column/column229.shtml

中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。